Core Viewpoint - A lawsuit has been filed against Evolv Technologies Holdings, Inc. and certain current and former executives, alleging material misstatements in financial statements related to revenue recognition from Q2 2022 to Q2 2024 [1][2][3] Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Massachusetts, captioned Buchan v. Evolv Technologies Holdings, Inc., No. 1:24-cv-12768 [2] - Investors have until December 31, 2024, to request to lead the case [2] Group 2: Financial Misstatements - Evolv's financial statements from Q2 2022 to Q2 2024 contained material misstatements regarding revenue recognition and other metrics [3] - On October 25, 2024, Evolv announced that its financial statements should not be relied upon due to these misstatements, revealing issues with sales to a major channel partner and misconduct by certain personnel [4] Group 3: Stock Price Impact - Following the announcement of financial misstatements, Evolv's stock price dropped approximately 40%, from $4.10 on October 24, 2024, to $2.47 on October 25, 2024 [4] - After the termination of CEO Peter George on October 31, 2024, the stock price fell about 8%, from $2.34 on October 30, 2024, to $2.15 on October 31, 2024 [5] Group 4: Legal Representation - Bleichmar Fonti & Auld LLP is representing plaintiffs in this case, with no upfront costs for shareholders [6][7] - The firm has a strong track record, having recovered over $900 million from Tesla's Board of Directors and $420 million from Teva Pharmaceutical Industries [8]

Core Viewpoint - A lawsuit has been filed against Evolv Technologies Holdings, Inc. and certain current and former executives, alleging material misstatements in financial statements related to revenue recognition from Q2 2022 to Q2 2024 [1][2][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Massachusetts, captioned Buchan v. Evolv Technologies Holdings, Inc., No. 1:24-cv-12768 [2]. - Investors have until December 31, 2024, to request to be appointed to lead the case [2]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. Group 2: Financial Misstatements - Evolv's financial statements from Q2 2022 to Q2 2024 contained material misstatements regarding revenue recognition and other metrics [3]. - The company revealed that certain sales were subject to extracontractual terms not disclosed to accounting personnel, and misconduct was involved in these transactions [4]. Group 3: Stock Price Impact - Following the announcement of the financial misstatements, Evolv's stock price dropped approximately 40%, from $4.10 on October 24, 2024, to $2.47 on October 25, 2024 [4]. - After the termination of CEO Peter George on October 31, 2024, the stock price fell about 8%, from $2.34 on October 30, 2024, to $2.15 on October 31, 2024 [5]. Group 4: Company Background - Evolv Technologies is a security technology company that utilizes AI-based screening to enhance safety [3]. - The company has self-reported issues to the SEC and is delaying its upcoming quarterly report for Q3 2024 [4].

Core Viewpoint - A class action lawsuit has been filed against Evolv Technologies Holdings, Inc. due to allegations of misleading investors regarding revenue recognition and material misstatements in financial statements [1][2]. Group 1: Allegations and Financial Impact - Evolv Technologies announced on October 25, 2024, that its financial statements from Q2 2022 to Q2 2024 should not be relied upon due to material misstatements affecting revenue recognition [2]. - The company disclosed that certain sales, particularly to a major channel partner, involved undisclosed extra-contractual terms and conditions, leading to misconduct by some personnel [2]. - Following this announcement, Evolv's stock price plummeted approximately 40%, dropping from $4.10 per share on October 24, 2024, to $2.47 per share on October 25, 2024 [2]. Group 2: Class Action Participation - Shareholders who wish to serve as lead plaintiffs in the class action must submit their applications by December 31, 2024 [3]. - Participation in the case is not required to be eligible for recovery; shareholders can remain absent class members if they choose [3]. Group 3: Legal Representation - Robbins LLP operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless the case is won [4]. - Robbins LLP is recognized for its commitment to shareholder rights litigation and has recovered over $1 billion for shareholders since its inception [5].

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating potential securities claims on behalf of purchasers of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) (“Evolv” or the “Company”). Evolv Technologies Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, develops AI-based touch-less screening technologies for weapons detection, ...

NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. (NASDAQ: EVLV, NHIC) resulting from allegations that Evolv may have issued materially misleading business information to the investing public.So What: If you purchased Evolv and/or NewHold Investment Corp. securities you may be entitled to compensation without pay ...

Core Viewpoint - Evolv Technologies Holdings, Inc. is under investigation for potential violations of federal securities laws following a significant drop in its stock price due to an internal investigation revealing material misstatements in revenue recognition dating back to 2022 [1][2]. Group 1: Company Financials - On October 25, 2024, Evolv Technologies announced a delay in filing its quarterly financial report due to the internal investigation [1]. - The investigation revealed that certain financial statements from 2022 to mid-2024 should not be relied upon, as undisclosed terms in sales to channel partners affected reported revenue [1]. Group 2: Stock Performance - The announcement led to a drastic decline in Evolv's stock price, which fell by more than 40% during trading on October 25, 2024 [2]. Group 3: Legal Implications - Bleichmar Fonti & Auld LLP is encouraging investors in Evolv Technologies to seek additional information regarding potential legal options [2].

NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Evolv Technologies Holdings, Inc. ("Evolv" or the "Company") (NASDAQ: EVLV) on behalf of Evolv stockholders. Our investigation concerns whether Evolv has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On October 25, 2024, before market hours, Evolv filed a Cur ...

We add real-time buy and sell signals on these, as well as other trading opportunities which we provide in our active chat community. We look at companies with a defensible competitive advantage and the opportunity and/or business models which have the potential to generate considerable operational leverage. If you are interested in similarly small, high-growth potential stocks you could join us at our marketplace service SHU Growth Portfolio , where we maintain a portfolio and a watchlist of similar stocks ...

Company Investigation - Leading securities law firm Bleichmar Fonti & Auld LLP is investigating Evolv Technologies Holdings Inc (NASDAQ: EVLV) for potential violations of federal securities laws [1] - The investigation follows Evolv's announcement of a delay in filing its quarterly financial report due to material misstatements in revenue recognition dating back to 2022 [1] - Evolv disclosed that certain financial statements from 2022 to mid-2024 should not be relied upon due to undisclosed terms in sales to channel partners, including one of its largest partners [1] Stock Performance - Evolv's stock price declined more than 40% during trading on October 25, 2024, following the announcement of the financial reporting issues [2] Legal Representation - Bleichmar Fonti & Auld LLP is a leading international law firm specializing in securities class actions and shareholder litigation [3] - The firm has achieved notable successes, including recovering over $900 million from Tesla Inc's Board of Directors and $420 million from Teva Pharmaceutical Ind Ltd [3] - BFA was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been recognized by Law360 and Thompson Reuters [3]

Core Viewpoint - Berman Tabacco is investigating potential securities law violations by Evolv Technologies Holdings, Inc. following the company's disclosure of an internal investigation into its sales practices [1][2]. Investigation Details - On October 25, 2024, Evolv filed a Form 8-K with the U.S. Securities and Exchange Commission, revealing that an independent committee has started investigating the company's sales practices [2]. - The committee found that certain sales, particularly to a major channel partner, involved extra-contractual terms not disclosed to the accounting team, indicating potential misconduct by company personnel [2]. - Preliminary findings suggest that the accounting for specific sales transactions was inaccurate, with revenue being prematurely or incorrectly recognized in financial statements from Q2 2022 to Q2 2024 [2].